Invizyne Technologies (NASDAQ:IZTC) Stock Falls 4.4% – Should You Sell?

Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report)’s share price was down 4.4% during trading on Thursday. The company traded as low as $5.7683 and last traded at $5.83. Approximately 2,034 shares traded hands during trading, a decline of 95% from the average daily volume of 37,647 shares. The stock had previously closed at $6.10.

Invizyne Technologies Stock Up 0.2%

The firm’s 50 day moving average is $6.04 and its two-hundred day moving average is $7.71.

About Invizyne Technologies

(Get Free Report)

Invizyne Technologies, Inc is a synthetic biology company developing technologies for the biological production of complex molecules. Its approach uses engineered enzymes and cell-free biomanufacturing systems to create chemical compounds without relying on traditional whole-cell fermentation.

The company’s platform is designed to support the development and production of pharmaceutical ingredients and other specialty chemicals. Potential applications include products for the pharmaceutical, agricultural, food, flavor and fragrance, and chemical industries.

Recommended Stories

Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.